|
| |
De Novo Pharmaceuticals LtdThe volume of structural protein data that will emerge in the next few years will serve as a driver that transforms the pharmaceutical industry. Over the next decade it is predicted that the high-resolution 3-D structure of all proteins that precisely define the biological space of human, pathogenic organisms and plant proteomes will be available. As this flood of data on proteins becomes available, De Novo is centrally positioned to efficiently link biological space to chemical space.
| Contact Details: |
| Compass HouseVision ParkHiston |
| Cambridge |
| Cambridgeshire |
| CB4 9ZR |
| United Kingdom |
| Tel: | 44 (0)1223 238000 |
| Fax: | |
| Email: | info@denovopharma.com |
| WWW: | www.denovopharma.com/

|
| |
Recent Publications by De Novo Pharmaceuticals Ltd: |  |
De novo ligand design to partially flexible active sites: application of the ReFlex algorithm to carboxypeptidase A, acetylcholinesterase, and the estrogen receptor.
Reflex is a recent algorithm in the de novo ligand design software,... | 6th May, 2008
| De Novo Pharmaceuticals Ltd., Compass House, Vision Park, Chivers Way,
| J Chem Inf Model. 2008 Feb;48(2):296-305. Epub 2008 Jan 31.
DOI Direct Link |
Chemical genomics: a challenge for de novo drug design.
De novo design provides an in silico toolkit for the design of novel small... | 12th January, 2008
| De Novo Pharmaceuticals Ltd., Vision Park, Compass House, Histon,
| Mol Biotechnol. 2007 Nov;37(3):237-45. Epub 2007 Jun 30.
DOI Direct Link |
Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen.
A de novo design approach to generating novel estrogen receptor (ER)... | 9th September, 2006
| De Novo Pharmaceuticals Ltd., Compass House, Vision Park, Histon,
| J Chem Inf Model. 2006 Mar-Apr;46(2):642-7.
DOI Direct Link |
De novo ligand design to an ensemble of protein structures.
We describe a combinatorial method for de novo ligand design to an... | 10th August, 2006
| De Novo Pharmaceuticals Ltd., Compass House, Cambridge, United Kingdom.
| Proteins. 2006 Jul 1;64(1):43-59.
DOI Direct Link |
Exhaustive de novo design of low-molecular-weight fragments against the ATP-binding site of DNA-gyrase.
We present a de novo design approach to generating small fragments in the... | 29th June, 2006
| De Novo Pharmaceuticals Ltd., Compass House, Vision Park, Histon,
| J Chem Inf Model. 2006 May-Jun;46(3):1168-73.
DOI Direct Link |
→View more De Novo Pharmaceuticals Ltd research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 157 times since April 2007, the link to the organisation's website has been followed 35 times Recent Search Terms used to find this page: De Novo Pharmaceuticals Ltd | . Search for more companies in Cambridge Search for more companies in Cambridgeshire This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for De Novo Pharmaceuticals Ltd |